Your session is about to expire
← Back to Search
Behavioural Intervention
Smartphone-Based Smoking Cessation Interventions for Smoking Cessation (Smart-TR01 Trial)
Phase 2 & 3
Waitlist Available
Led By Michael S Businelle, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 27 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests the Smart-T app, which helps low-income smokers quit by sending personalized messages when they are most likely to smoke. The app uses real-time data to support users in managing their cravings. The study aims to see if the Smart-T app is more effective than other smoking cessation apps.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 27 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~27 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Biochemically-Verified Smoking Cessation
Secondary study objectives
Change in cessation motivation
Change in cigarette availability
Change in smoking urge
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Smart-T + NRTExperimental Treatment1 Intervention
Smart-T provides content during the pre-quit and post-quit periods to prepare and support participants during their quit attempt. The Smart-T app contains multiple components including an EMA delivery and data transfer system, automated messages based upon EMA responses, and on-demand content. All participants will receive free nicotine replacement therapy (NRT).
Group II: NCI QuitGuide + NRTActive Control1 Intervention
The National Cancer Institute's QuitGuide app is a free smartphone app and is one of few apps that includes many of the recommendations detailed in the Clinical Practice Guideline. The QuitGuide app aims to help smokers understand their smoking patterns and develop the skills needed to quit smoking. QuitGuide provides content during the pre-quit and post-quit periods to prepare and support participants during their quit attempt. All participants will receive free nicotine replacement therapy (NRT).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smart-T + NRT
2019
Completed Phase 3
~460
Find a Location
Who is running the clinical trial?
University of OklahomaLead Sponsor
474 Previous Clinical Trials
93,238 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,957 Previous Clinical Trials
41,111,634 Total Patients Enrolled
Michael S Businelle, PhDPrincipal InvestigatorUniversity of Oklahoma
1 Previous Clinical Trials
500 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are willing to stop smoking one week after your first visit.You smoke at least 5 cigarettes every day.
Research Study Groups:
This trial has the following groups:- Group 1: Smart-T + NRT
- Group 2: NCI QuitGuide + NRT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.